As of Nov 27
| +0.33 / +1.70%|
The 5 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 20.00, with a high estimate of 23.00 and a low estimate of 15.00. The median estimate represents a +1.11% increase from the last price of 19.78.
The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.